Articles dans des revues avec comité de lecture (144)
  1. 141. Verdin, E., & Van Lint, C. (1995). Internal transcriptional regulatory elements in HIV-1 and other retroviruses. Cellular and molecular biology, 41(3), 365-369.
  2. 142. Van Lint, C., Ghysdael, J., Paras, P., Burny, A., & Verdin, E. (1994). A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. Journal of virology, 68(4), 2632-2648.
  3. 143. Verdin, E., Paraskevas, P., & Van Lint, C. (1993). Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO journal, 12(8), 3249-3259. doi:10.1002/j.1460-2075.1993.tb05994.x
  4. 144. Van Lint, C., Burny, A., & Verdin, E. (1991). The intragenic enhancer of human immunodeficiency virus type 1 contains functional AP-1 binding sites. Journal of virology, 65(12), 7066-7072.
    5.   Communications publiées lors de congrès ou colloques nationaux et internationaux (118)
  5. 1. Van Lint, C. (2019). THE CURRENT STATUS OF LATENCY REVERSING AGENTS. EXPRESS YOURSELF: PROVIRUS Conference on Retroviruses and Opportunistic Infections(March 4 to March 7, 2019: Seattle, Washington DC, United States)
  6. 2. Rodari, A., Van Driessche, B., Galais, M., Delacourt, N., Fauquenoy, S., Vanhulle, C., Kula, A., Burny, A., Rohr, O., & Van Lint, C. (2016). Characterization of new RNA polymerase III and RNA polymerase II transcriptional promoters in the Bovine Leukemia Virus genome. Frontiers of Retrovirology Conference 2016: Complex retroviruses, retroelements and their hosts Frontiers of Retrovirology(12-14 Septembre 2016: Erlangen)
  7. 3. Prado, J., Noel, N., Pen, R., David, D., Avettand, V., Erkisson, I., Jiménez, E., Lecuroux, C., Rouzioux, C., Boufassa, F., Pancino, G., Venet, A., Van Lint, C., Martinez-Picado, J., Lambotte, O., & Saez-cirion, A. (2015). Long-term spontaneous control of HIV-1 relates to low frequency of infected cells and inefficient viral reactivation. 7th international workshop: HIV Persistence during Therapy
  8. 4. Vicenzi, E., Turrini, F., Marelli, S., Kajaste-Rudnitski, A., Van Lint, C., Das, A. T., Berkhout, B., & Poli, G. (2015). HIV-1 silencing mediated by TRIM22 inhibition of Sp1 binding to the promoter. 7th international workshop: HIV Persistence during Therapy
  9. 5. Van Lint, C., Bouchat, S., Delacourt, N., Kula, A., Darcis, G., Corrazza, F., Gatot, J.-S., Melard, A., Vanhulle, C., Van Driessche, B., Kabeya, K., Pardons, M., Avettand, V., Clumeck, N., De Wit, S., Rohr, O., & Rouzioux, C. (2015). Sequential Treatment with 5-aza-2’deoxycitidin and Desacetylase Inhibitors Reactivates HIV-1. 7th international workshop: HIV Persistence during Therapy
  10. 6. Forouzanfard, F., Ali, S., Le Douce, V., El Maasarrani, M., Ait-Ammar, A., Janossy, A., Candolfi, E., Margotin-Goguet, F., Van Lint, C., Schwartz, C., & Rohr, O. (2015). Viral counteractions against CTIP2 in HIV-1 permissive cells. 7th international workshop: HIV Persistence during Therapy
  11. 7. Rodari, A., Van Driessche, B., Delacourt, N., Vanhulle, C., Burny, A., Van Den Broeke, A., Rohr, O., & Van Lint, C. (2015). In vivo characterisation of the BLV miRNA cluster. Abstract of the 17th International Conference on Human Retrovirology : HTLV & related Viruses
  12. 8. Kula, A., Darcis, G., Bouchat, S., Kabeya, K., Delacourt, N., Vanhulle, C., Robette, G., Burny, A., Clumeck, N., Rohr, O., Moutschen, M., Rouzioux, C., De Wit, S., & Van Lint, C. (2014). Reactivation of postintegration HIV-1 latency : potential therapeutic approach to purge the viral reservoirs. Abstract of Metabolism 2014 (29-31 Jan, 2014: Esch Sur Alzette, Luxembourg)
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Suivant >>